Pan-European private equity investor Oakley Capital, via its Oakley Capital Fund V, has invested in ProductLife Group, a European provider of outsourced development, regulatory and compliance services to the global life sciences industry.
According to a press statement, Oakley will work alongside management and reinvesting shareholder 21 Invest to support the company’s continued international expansion, as well as accelerating investments into AI technology to drive technology enablement of its services and operations.
ProductLife Group provides development, regulatory affairs, market access, pharmacovigilance, quality management and digital transformation services mainly to clients in the pharmaceuticals industry. Under the leadership of Xavier Duburcq, ProductLife Group has completed 16 add-on acquisitions. ProductLife Group currently employs more than 1,600.
